ST Elevation Myocardial Infarction clinical trials
The registry lists 850 studies for ST Elevation Myocardial Infarction across more than 10 countries. 197 are recruiting or about to start. 617 of them are mainly about ST Elevation Myocardial Infarction (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.
ClinicalTrials.gov finds 1,309 studies for ST Elevation Myocardial Infarction. How that becomes 850 here
This page counts the studies the registry files under ST Elevation Myocardial Infarction, and those it files under no condition that list ST Elevation Myocardial Infarctionthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count
- 1,309Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
- −7List ST Elevation Myocardial Infarction as a condition, but the registry did not file them under itMost often written as “Acute ST Elevation Myocardial Infarction” (1), “Segment Elevation Myocardial Infarction (STEMI)” (1), and “Patients With ST-elevated Myocardial Infarction” (1). The registry filed them under other conditions only, most often Myocardial Infarction (2) and Angina, Stable (2).
- −452Match it another way218 name it in the title, 10 in a keyword, and 224 by a synonym or other text the search reads.
- 850The count on this page21 of them list ST Elevation Myocardial Infarction in their own words; the registry filed them under no condition.
Get an email when these change. Save the ST Elevation Myocardial Infarction studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
Assiut University (36) · RenJi Hospital (13) · Rigshospitalet, Denmark (10) · Assistance Publique - Hôpitaux de Paris (9) · Chinese PLA General Hospital (9) · Beijing Anzhen Hospital (8) · Karolinska Institutet (8) · Samsung Medical Center (7)
What is being tested here
Drugs under test in ST Elevation Myocardial Infarction studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Dapagliflozin | 5 | 6 | 9 |
| Rivaroxaban | 3 | 3 | 7 |
| Evolocumab | 2 | 1 | 8 |
| Colchicine | 2 | 2 | 7 |
| Empagliflozin | 2 | 0 | 3 |
| Bempedoic acid | 2 | 0 | 3 |
| Methoxyflurane | 2 | 2 | 2 |
| Inclisiran | 2 | 1 | 2 |
| Bivalirudin | 1 | 2 | 10 |
| Atorvastatin | 1 | 2 | 9 |
Drug classes tested here SGLT2 inhibitors 6 open · Statins 2 open · PCSK9 inhibitors 2 open · Thrombolytics 1 open · Corticosteroids 1 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Jan 2027Epicardial Cardiac Fat-CT (EPIC-CT) · Phase 3 · Instituto Mexicano del Seguro Social
- Feb 2027Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes · Phase 3 · Novartis Pharmaceuticals
- Jun 2027Dapagliflozin in STEMI · Phase 3 · Ottawa Heart Institute Research Corporation
- Jul 2027Comparative Evaluation of Sustained meChanical AsPiration Thrombectomy and no Thrombus Modification for Pre-stent Thrombus bUrden Reduction in Patients With Acute Myocardial Infarction Study: the CAPTURE AMI Study · Phase 3 · Oxford University Hospitals NHS Trust
- Nov 2026TIRANA-ACS: A Prospective Registry Study for the Targeted Investigation of Residual Inflammation After Non-ST/ ST Elevation Acute Coronary Syndrome · University Hospital Centre Mother Teresa
- Nov 2026Smartphone AI Assistance for Prehospital ECG Interpretation · École Supérieure de Soins Ambulanciers - College of Higher Education in Prehospital Care
- Dec 2026Evaluating the Safety and Efficacy of Drug-Coated Autoperfusion Balloons Versus Conventional Drug-Coated Balloons Guided by IVUS-OCT Multimodal Imaging for Treating Acute Myocardial Infarction: OPERA-AMI Study · LanZhou University
- Dec 2026Low-dose Evaluation of Aspirin After STEMI Patients With PCI: A Multicenter, Double-blind, Randomized Controlled Clinical Trial · Beijing Anzhen Hospital
- Dec 2026Effect of Digitally Supported Medical Nutrition Therapy on Left Ventricular Ejection Fraction in Patients With ST-Elevation Myocardial Infarction · Saglik Bilimleri Universitesi
- Dec 2026Platelet Derived Growth Factor Receptor ß (PDGFRß) Imaging in Cardiac Fibrosis · Uppsala University
Who these studies take
Of the 122 ST Elevation Myocardial Infarction studies recruiting now, 76 (62%) set no upper age limit and 20 (16%) stop at 75 or younger. 10 (8%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 9 (7%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 8 (7%) | 8 (7%) |
| 18 | 112 (92%) | 112 (92%) |
| 30 | 119 (98%) | 119 (98%) |
| 40 | 121 (99%) | 121 (99%) |
| 50 | 120 (98%) | 120 (98%) |
| 65 | 120 (98%) | 120 (98%) |
| 75 | 115 (94%) | 115 (94%) |
| 85 | 81 (66%) | 81 (66%) |
Across all 850 studies, recruiting or not: 14% stop at 75 or younger and 2% at 65; 9% take children; <1% are for women only and <1% for men only; 4% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long ST Elevation Myocardial Infarction studies take
Of 49 phase 4 interventional studies under ST Elevation Myocardial Infarction, half reached primary completion within 34 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 2 | 26 mo14–39 · 31 studies | — | — |
| Phase 3 | 37 mo23–58 · 38 studies | — | — |
| Phase 4 | 34 mo22–63 · 49 studies | — | 34 mo21–74 · 44 studies |
| Interventional, no phase | 38 mo19–64 · 143 studies | — | 38 mo19–64 · 134 studies |
| Observational | 38 mo20–73 · 143 studies | — | 41 mo18–107 · 122 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 13, 2026.
Started recruiting2
- Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary SyndromeNov 5, 2026NCT07684742
- Breisgau PHENO-HEART MIOct 27, 2026NCT06166407
Stopped1
Newly registered7
- Incremental Prognostic Utility of CBC-derived Inflammatory Indices After Incomplete Coronary Revascularization: Association With 12-months Cardiovascular OutcomesNov 4, 2026NCT07916701
- Reducing Slow/No-Reflow With Prophylactic High-Dose Intracoronary Adenosine Protocol in ST-Elevation Myocardial Infarction The REFLOW AMI TrialOct 27, 2026NCT07898696
- Evaluating SGLT2 Inhibitors for the Reduction of No-Reflow Phenomenon in Patients Undergoing PCIOct 27, 2026NCT07898709
- Integrated Assessment of Immune-Inflammatory and Metabolic Biomarkers for Prediction of Coronary No-Reflow Following Primary PCI in STEMI PatientsOct 22, 2026NCT07890168
- AI-ECG Detection of Occlusion Myocardial Infarction at Emergency Department Triage (TRIACS)Oct 20, 2026NCT07882849
Show 2 moreShow fewer
- IMPROVE-STEMI: pPCI Plus Low-dose r-SK in STEMIOct 15, 2026NCT07875179
- Multimodality Assessment of Myocardial Reperfusion After Primary Percutaneous Coronary InterventionOct 15, 2026NCT07876791
Studies
Recruiting first, then most recently updated. Showing 50 of 850. Browse all 850 → or search them.
- Rituximab in Patients With ST-elevation Myocardial InfarctionRecruitingNCT05211401Phase 21 country
- Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary SyndromeRecruitingNCT07684742Phase 41 country
- Incremental Prognostic Utility of CBC-derived Inflammatory Indices After Incomplete Coronary Revascularization: Association With 12-months Cardiovascular OutcomesNot yet recruitingNCT07916701
- Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial InfarctionRecruitingNCT07362446Phase 21 country
- SuperSaturated Oxygen Comprehensive Observational RegistryRecruitingNCT064383151 country
- Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation Myocardial InfarctionRecruitingNCT05410925Phase 41 country
- Evaluating SGLT2 Inhibitors for the Reduction of No-Reflow Phenomenon in Patients Undergoing PCINot yet recruitingNCT07898709Phase 21 country
- Breisgau PHENO-HEART MIRecruitingNCT061664071 country
- Reducing Slow/No-Reflow With Prophylactic High-Dose Intracoronary Adenosine Protocol in ST-Elevation Myocardial Infarction The REFLOW AMI TrialRecruitingNCT07898696Not applicable1 country
- Integrated Assessment of Immune-Inflammatory and Metabolic Biomarkers for Prediction of Coronary No-Reflow Following Primary PCI in STEMI PatientsRecruitingNCT078901681 country
- AI-ECG Detection of Occlusion Myocardial Infarction at Emergency Department Triage (TRIACS)Not yet recruitingNCT078828491 country
- Metabolic Characteristics of Plasma OxPLs in STEMI Patients.Enrolling by invitationNCT073827001 country
- IMPROVE-STEMI: pPCI Plus Low-dose r-SK in STEMINot yet recruitingNCT07875179Phase 41 country
- STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPTRecruitingNCT05785897Not applicable1 country
- Multimodality Assessment of Myocardial Reperfusion After Primary Percutaneous Coronary InterventionNot yet recruitingNCT07876791
- Analysis of Life-threatening ARrhythMias After Acute Coronary SyndromeRecruitingNCT078240501 country
- Clonal Hematopoiesis of Indeterminate Potential and Infarct Severity in ST-Elevation Myocardial InfarctionRecruitingNCT076150231 country
- Gangwon PCI Prospective RegistryRecruitingNCT020381271 country
- CRP Apheresis in STEMIRecruitingNCT04939805Not applicable2 countries
- On vs Off-hour PPCI in STEMI PatientsNot yet recruitingNCT078600861 country
- Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous Saline ThermodilutionRecruitingNCT067950351 country
- Germany on Target RegistryNot yet recruitingNCT07835282
- Drug-Coated Balloon Versus Drug-Eluting Stent in Patient With ST-Segment Elevation Myocardial InfarctionRecruitingNCT06742125Not applicable1 country
- The FAVOR V AMI TrialRecruitingNCT05669222Not applicable1 country
- Evaluate the Efficacy and Safety of Allogeneic Umbilical Cord Mesenchymal Stem Cells as an Add-On Treatment for Acute ST-elevation Myocardial Infarction (STEMI) PatientsRecruitingNCT06147986Phase 21 country
- CHIP in Health and DiseaseNot yet recruitingNCT077805521 country
- Beyond the Mehran Risk Score: Predictive Value of Total Ischemic Time for Contrast-Induced Nephropathy in ST Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention.Not yet recruitingNCT07826572
- Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary SyndromeRecruitingNCT07824323Phase 41 country
- Hong Kong Cardiogenic Shock InitiativeNot yet recruitingNCT073232381 country
- Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary SyndromesRecruitingNCT07102628Phase 314 countries
- Effect and Safety of Fexofenadine Hydrochloride vs Placebo in Patients With Acute Myocardial Infaction: A Randomized Clinical TrialRecruitingNCT06548204Phase 21 country
- Optimal Timing of Microaxial Flow Pump(Impella CP) in AMI-related Cardiogenic ShockNot yet recruitingNCT07817472Not applicable1 country
- Thrombus Aspiration in STEMI Patients With High Thrombus BurdenRecruitingNCT04212494Not applicable1 country
- Smartphone AI Assistance for Prehospital ECG InterpretationRecruitingNCT07810686Not applicable1 country
- Manual Thrombus Aspiration During PCI in STEMI With Angiographically Evident ThrombusRecruitingNCT06654453Not applicable1 country
- A Single-Center, Retrospective, Propensity-Score-Matched Cohort Study Comparing Drug-Coated Balloon Versus Drug-Eluting Stent for Reducing Immediate Post-Procedural Slow-Flow/No-Reflow in Acute ST-Elevation Myocardial Infarction Patients With High Thrombus BurdenRecruitingNCT078063701 country
- The Effect of Hydration on the Prevention of CI-AKI in STEMI Patients Undergoing Primary PCI (Hydro-AKI Trial)Not yet recruitingNCT07761754Not applicable
- CORonary Thrombus Modification to Prevent MIcrovascular Damage in Patients With ST-segment Elevation Myocardial Infarction (The CORMI Trial)RecruitingNCT07646977Not applicable1 country
- Abbreviated Antithrombotic Therapy After PCI in Patients With AF and AMIRecruitingNCT07583784Not applicable1 country
- SMARTwatch for the Diagnosis of ST-segment Elevation Myocardial Infarction in Patients With Chest PainRecruitingNCT077809421 country
- Efficacy and Safety of Ultrasound Modulation of Stellate Ganglion for the Prevention of Ventricular Arrhythmia in Patients With ST-segment Elevation Myocardial InfarctionRecruitingNCT07587294Not applicable1 country
- Combined Antioxidant Therapy for Acute Myocardial InfarctionNot yet recruitingNCT07776288Phase 21 country
- Noninvasive Artificial Venous Stasis for Reperfusion in STEMIRecruitingNCT076895911 country
- Prophylactic IABP in Delayed-Presentation Anterior STEMINot yet recruitingNCT07761455Not applicable1 country
- Timing of Empagliflozin in Primary PCI: Pre-Reperfusion Versus Post-Reperfusion Versus Placebo in South Asian STEMI PatientsNot yet recruitingNCT07749014Phase 21 country
- Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)RecruitingNCT07567625Not applicable1 country
- Insulin Resistance and Its Association With no Reflow Phenomenon After Primary PCI in Type II Diabetic STEMI Patients.Not yet recruitingNCT07706335
- A Research Study to Evaluate the Efficacy and Safety of SGC001 in Patients With Anterior Wall ST-Segment Elevation Myocardial InfarctionRecruitingNCT07306182Phase 21 country
- Comparative Evaluation of Sustained meChanical AsPiration Thrombectomy and no Thrombus Modification for Pre-stent Thrombus bUrden Reduction in Patients With Acute Myocardial Infarction Study: the CAPTURE AMI StudyRecruitingNCT07687576Phase 2/31 country
- Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI PatientsRecruitingNCT05491200Phase 46 countries